• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Steatosis assessment by controlled attenuation parameter in patients with compensated advanced chronic liver disease.

作者信息

Grgurevic Ivica, Salkic Nermin, Madir Anita, Aralica Gorana

机构信息

Department of Gastroenterology, Hepatology and Clinical Nutrition, University Hospital Dubrava, University of Zagreb School of Medicine and Faculty of Pharmacy and Biochemistry, Zagreb, Croatia.

Department of Gastroenterology and Hepatology, University Hospital Centre Tuzla, Tuzla, Bosnia and Herzegovina.

出版信息

Liver Int. 2020 Jul;40(7):1784-1785. doi: 10.1111/liv.14426. Epub 2020 Mar 17.

DOI:10.1111/liv.14426
PMID:32145702
Abstract
摘要

相似文献

1
Steatosis assessment by controlled attenuation parameter in patients with compensated advanced chronic liver disease.
Liver Int. 2020 Jul;40(7):1784-1785. doi: 10.1111/liv.14426. Epub 2020 Mar 17.
2
The clinical value of controlled attenuation parameter for the noninvasive assessment of liver steatosis.受控衰减参数在非侵入性评估肝脂肪变性中的临床价值。
Liver Int. 2016 Dec;36(12):1860-1866. doi: 10.1111/liv.13207. Epub 2016 Aug 6.
3
Getting closer to a point-of-care diagnostic assessment in patients with chronic liver disease: controlled attenuation parameter for steatosis.在慢性肝病患者中更接近即时诊断评估：脂肪变性的受控衰减参数
J Hepatol. 2014 May;60(5):910-2. doi: 10.1016/j.jhep.2014.01.017. Epub 2014 Jan 31.
4
How good is controlled attenuation parameter and fatty liver index for assessing liver steatosis in general population: correlation with ultrasound.在普通人群中，控制衰减参数和脂肪肝指数评估肝脂肪变性的效果如何：与超声的相关性
Liver Int. 2014 Jul;34(6):e111-7. doi: 10.1111/liv.12305. Epub 2013 Sep 4.
5
Controlled attenuation parameter for the detection of steatosis severity in chronic liver disease: a meta-analysis of diagnostic accuracy.用于检测慢性肝病脂肪变性严重程度的受控衰减参数：诊断准确性的荟萃分析
J Gastroenterol Hepatol. 2014 Jun;29(6):1149-58. doi: 10.1111/jgh.12519.
6
[Controlled attenuation parameter is a novel technique in screening for non-alcoholic fatty liver disease].[受控衰减参数是筛查非酒精性脂肪性肝病的一项新技术]
Ugeskr Laeger. 2018 Jan 29;180(5).
7
The controlled attenuation parameter (CAP): a novel tool for the non-invasive evaluation of steatosis using Fibroscan.受控衰减参数（CAP）：利用 Fibroscan 进行非侵入性评估脂肪变性的新工具。
Clin Res Hepatol Gastroenterol. 2012 Feb;36(1):13-20. doi: 10.1016/j.clinre.2011.08.001. Epub 2011 Sep 15.
8
Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease.用于非酒精性脂肪性肝病中肝脂肪变性检测和定量的受控衰减参数
J Gastroenterol Hepatol. 2014;29(7):1470-6. doi: 10.1111/jgh.12557.
9
Controlled attenuation parameter (CAP) for the diagnosis of steatosis: a prospective study of 5323 examinations.受控衰减参数（CAP）诊断脂肪变：5323 次检查的前瞻性研究。
J Hepatol. 2014 May;60(5):1026-31. doi: 10.1016/j.jhep.2013.12.018. Epub 2013 Dec 28.
10
Diagnostic accuracy of controlled attenuation parameter measured by transient elastography for the non-invasive assessment of liver steatosis: a prospective study.瞬时弹性成像测量控制衰减参数对肝脂肪变性无创评估的诊断准确性：一项前瞻性研究
J Gastrointestin Liver Dis. 2015 Mar;24(1):35-42. doi: 10.15403/jgld.2014.1121.mlp.

引用本文的文献

1
Ultrasound Methods for the Assessment of Liver Steatosis: A Critical Appraisal.评估肝脏脂肪变性的超声方法：批判性评价
Diagnostics (Basel). 2022 Sep 22;12(10):2287. doi: 10.3390/diagnostics12102287.
2
Use of biochemical parameters for non-invasive screening of oesophageal varices in comparison to elastography-based approach in patients with compensated advanced chronic liver disease.应用生化参数对代偿期慢性肝病进展期患者进行非侵入性食管静脉曲张筛查与基于弹性成像的方法比较。
Biochem Med (Zagreb). 2022 Jun 15;32(2):020712. doi: 10.11613/BM.2022.020712.
3
Ultrasound Elastography-Cornerstone of Non-Invasive Metabolic Dysfunction-Associated Fatty Liver Disease Assessment.
超声弹性成像——非侵入性代谢功能相关脂肪性肝病评估的基石。
Medicina (Kaunas). 2021 May 21;57(6):516. doi: 10.3390/medicina57060516.
4
Liver and Nonliver-Related Outcomes at 2 Years Are Not Influenced by the Results of the FIB-4 Test and Liver Elastography in a Real-Life Cohort of Patients with Type 2 Diabetes.在 2 年时，肝和非肝相关结局不受 FIB-4 测试和肝脏弹性成像结果的影响，这在 2 型糖尿病患者的真实队列中得到证实。
Can J Gastroenterol Hepatol. 2021 Mar 8;2021:5582813. doi: 10.1155/2021/5582813. eCollection 2021.